401 related articles for article (PubMed ID: 32859114)
1. Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma.
Teng CF; Wu HC; Su IJ; Jeng LB
Viruses; 2020 Aug; 12(9):. PubMed ID: 32859114
[TBL] [Abstract][Full Text] [Related]
2. Approaches for Detection of Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins and Their Application in Prediction of Higher Risk of Hepatocellular Carcinoma Development and Recurrence.
Lin YT; Jeng LB; Su IJ; Teng CF
Viruses; 2022 Feb; 14(2):. PubMed ID: 35216021
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins: Clinical and Molecular Implications in Hepatocellular Carcinoma.
Lin YT; Jeng LB; Chan WL; Su IJ; Teng CF
Viruses; 2021 May; 13(5):. PubMed ID: 34066744
[TBL] [Abstract][Full Text] [Related]
4. Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma.
Tsai HW; Lin YJ; Wu HC; Chang TT; Wu IC; Cheng PN; Yen CJ; Chan SH; Huang W; Su IJ
Oncotarget; 2016 May; 7(19):27724-34. PubMed ID: 27027237
[TBL] [Abstract][Full Text] [Related]
5. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
[TBL] [Abstract][Full Text] [Related]
6. Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.
Wei Q; Xu X; Ling Q; Zhou B; Zheng SS
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):251-5. PubMed ID: 23742769
[TBL] [Abstract][Full Text] [Related]
7. Next-Generation Sequencing-Based Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma Predicts Hepatocellular Carcinoma Recurrence.
Teng CF; Li TC; Huang HY; Lin JH; Chen WS; Shyu WC; Wu HC; Peng CY; Su IJ; Jeng LB
Viruses; 2020 Jul; 12(8):. PubMed ID: 32722114
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
[TBL] [Abstract][Full Text] [Related]
9. Study of Preoperative Antiviral Treatment of Patients with HCC Negative for HBV-DNA.
Liu XF; Zhang T; Tang K; Sui LL; Xu G; Liu Q
Anticancer Res; 2017 Aug; 37(8):4701-4706. PubMed ID: 28739774
[TBL] [Abstract][Full Text] [Related]
10. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
[TBL] [Abstract][Full Text] [Related]
11. Detection of hepatitis B virus pre-S mutants in plasma by a next-generation sequencing-based platform determines their patterns in liver tissues.
Teng CF; Tsai HW; Li TC; Wang T; Wang J; Shyu WC; Wu HC; Su IJ; Jeng LB
PLoS One; 2020; 15(6):e0234773. PubMed ID: 32559248
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma levels of monocyte chemoattractant protein-1 in patients with hepatitis B virus pre-S2 gene deletion mutation predict a higher risk of hepatocellular carcinoma recurrence after curative surgical resection.
Jeng LB; Li TC; Wang J; Teng CF
Cancer; 2023 Sep; 129(17):2621-2636. PubMed ID: 37096803
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus surface gene pre-S
Yen CJ; Ai YL; Tsai HW; Chan SH; Yen CS; Cheng KH; Lee YP; Kao CW; Wang YC; Chen YL; Lin CH; Liu T; Tsai HP; Wang JR; Su IJ; Huang W
Hepatology; 2018 Sep; 68(3):815-826. PubMed ID: 29350774
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
16. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
17. Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term.
Haga H; Saito T; Okumoto K; Tomita K; Katsumi T; Mizuno K; Nishina T; Watanabe H; Ueno Y
J Viral Hepat; 2019 Jul; 26(7):866-872. PubMed ID: 30924226
[TBL] [Abstract][Full Text] [Related]
18. The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.
Urabe A; Imamura M; Tsuge M; Kan H; Fujino H; Fukuhara T; Masaki K; Kobayashi T; Ono A; Nakahara T; Kawaoka T; Hiramatsu A; Kawakami Y; Aikata H; Hayes CN; Maki N; Ohdan H; Chayama K
J Gastroenterol; 2017 Mar; 52(3):366-375. PubMed ID: 27422771
[TBL] [Abstract][Full Text] [Related]
19. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B.
Yeung P; Wong DK; Lai CL; Fung J; Seto WK; Yuen MF
J Infect Dis; 2011 Mar; 203(5):646-54. PubMed ID: 21227916
[TBL] [Abstract][Full Text] [Related]
20. Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw.
Tsubota A; Arase Y; Ren F; Tanaka H; Ikeda K; Kumada H
J Med Virol; 2001 Oct; 65(2):257-65. PubMed ID: 11536231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]